Sabra Health Care REIT stock (US78396U1051): dividend-focused healthcare landlord after latest earnings update
Sabra Health Care REIT remains focused on providing stable dividends from its US senior housing and skilled nursing portfolio, as highlighted by its recent first-quarter 2026 results. The company's business model relies on long-term leases generating stable rental income, with a requirement to distribute at least 90% of taxable income as dividends. With normalized FFO per share stable and affirmed full-year guidance, Sabra aims to attract income-focused investors despite ongoing industry pressures.
Sabra Reports Third Quarter 2024 Results; Updates 2024 Guidance
Sabra Health Care REIT Inc. (SBRA) has reported its third-quarter 2024 results and updated its guidance for the full year 2024. This information was made available through a press release and an SEC Form 8-K filing. Quantisnow, a real-time market data platform, alerted its Plus members about the publication and provides further details and related SEC filings for SBRA.
Sabra Healthcare REIT, Inc. $SBRA Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al
VIRGINIA RETIREMENT SYSTEMS ET Al significantly reduced its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 46.3% in the fourth quarter, selling 267,650 shares. Despite this, institutional investors and hedge funds still hold 99.40% of the stock, with other major holders like Vanguard and Principal Financial increasing their positions. Sabra Healthcare REIT reported quarterly EPS of $0.16, matching analyst estimates, and increased its quarterly dividend to $0.30 per share, offering a 5.7% annual yield.
Sabra Healthcare REIT stock hits 52-week high at 21.07 USD
Sabra Healthcare REIT Inc. (SBRA) has reached a new 52-week high, closing at $21.07, marking a 26% stock price increase over the past year. The company's $5.3 billion market cap and 5.72% dividend yield, along with strong Q1 2026 earnings exceeding revenue projections, are contributing factors. Analyst Cantor Fitzgerald raised its price target to $22.00, reflecting positive market sentiment and investor confidence in Sabra Healthcare's performance and growth prospects.
Sabra Healthcare REIT stock hits 52-week high at 21.07 USD
Sabra Healthcare REIT (SBRA) stock has reached a new 52-week high of $21.07, marking a 26% increase over the past year and a nearly 16% return in the last six months. The company reported strong Q1 2026 earnings, exceeding revenue projections, and analysts like Cantor Fitzgerald have raised price targets, reflecting positive market sentiment and investor confidence in its performance and growth prospects. SBRA also offers a 5.72% dividend yield and is considered slightly undervalued according to an InvestingPro analysis.
Sabra Healthcare REIT stock hits 52-week high at 21.07 USD
Sabra Healthcare REIT (SBRA) has reached a new 52-week high of $21.07, demonstrating a 26% stock price increase over the past year and a 16% return in the last six months. The company, with a $5.3 billion market cap, offers a 5.72% dividend yield and has maintained payments for 16 consecutive years. Despite its recent surge, InvestingPro analysis suggests the stock is still slightly undervalued.
Sabra Healthcare REIT Is Maintained at Neutral by Cantor Fitzgerald
Cantor Fitzgerald has maintained its Neutral rating on Sabra Healthcare REIT (SBRA). The report, issued 13 hours ago, reflects the firm's ongoing assessment of SBRA's financial position and market outlook.
Is Higher Q1 Revenue And An Affirmed Dividend Altering The Investment Case For Sabra (SBRA)?
Sabra Health Care REIT announced first-quarter 2026 results with US$221.75 million in revenue and affirmed a quarterly dividend of US$0.30 per share, despite a slight decrease in EPS. The article examines whether these results impact the investment thesis, noting the importance of sustained senior housing demand and a maintained dividend to its investment narrative. While the dividend affirmation is central, the high payout ratio and potential strain on the balance sheet for acquisitions remain key risks.
Cantor Fitzgerald raises Sabra Healthcare REIT price target to $22
Cantor Fitzgerald has increased its price target for Sabra Healthcare REIT Inc. (NASDAQ:SBRA) to $22.00 from $21.00, while maintaining a Neutral rating. The firm acknowledged Sabra Healthcare's extensive experience in senior housing operations and its solid financial health, highlighted by 16 consecutive years of dividend payments and a 5.78% yield. This comes as Sabra Healthcare recently exceeded revenue expectations in its Q1 2026 earnings report, further indicating strong financial performance.
UBS Group AG Raises Position in Sabra Healthcare REIT, Inc. $SBRA
UBS Group AG significantly increased its stake in Sabra Healthcare REIT, Inc. (SBRA) by 143.1% in the fourth quarter, bringing its total holdings to 1,460,219 shares valued at approximately $27.7 million. The REIT reported robust Q1 results, meeting EPS expectations and exceeding revenue estimates with a 20.9% year-over-year increase. Sabra Healthcare also declared a quarterly dividend of $0.30 per share, annualizing to a 5.8% yield, while analysts maintain a "Moderate Buy" rating with a $22 target price.
Sabra Healthcare REIT (NASDAQ:SBRA) Rating Lowered to "Sell" at Wall Street Zen
Wall Street Zen has downgraded Sabra Healthcare REIT (NASDAQ:SBRA) from "hold" to "sell," despite a "Moderate Buy" consensus from other analysts and a $22.00 price target. The company reported quarterly EPS of $0.16, meeting expectations, and revenue of $221.75 million, which was above estimates and up 20.9% year-over-year. Institutional investors have made minor adjustments to their holdings in SBRA, which currently has 99.40% ownership by institutional investors and hedge funds.
Sabra Healthcare REIT (SBRA) Stock Price, News & Analysis
This article provides a comprehensive overview of Sabra Healthcare REIT (SBRA), including its current stock price, recent news, and detailed financial analysis. It covers key statistics, company operations, analyst ratings, earnings forecasts, dividend information, and institutional ownership, indicating a "Moderate Buy" consensus rating despite concerns about dividend sustainability.
Mitsubishi UFJ Trust & Banking Corp Sells 111,862 Shares of Sabra Healthcare REIT, Inc. $SBRA
Mitsubishi UFJ Trust & Banking Corp significantly reduced its stake in Sabra Healthcare REIT (NASDAQ: SBRA) by 75.2% in Q4, selling over 111,000 shares but still holding 36,884 shares worth $699,000. Despite this, Sabra Healthcare REIT has a "Moderate Buy" consensus rating from analysts with a $22.00 price target and recently declared a quarterly dividend of $0.30 per share. The company reported Q1 EPS of $0.16, meeting estimates, and revenue of $221.75 million, exceeding expectations, while providing FY 2026 EPS guidance of $1.550-$1.590.
Principal Financial Group Inc. Acquires 4,431,897 Shares of Sabra Healthcare REIT, Inc. $SBRA
Principal Financial Group Inc. increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 21.6%, acquiring over 4.4 million additional shares, bringing its total ownership to 10.01% valued at approximately $472.6 million. Sabra Healthcare REIT reported Q4 EPS of $0.16, meeting estimates, and revenue of $221.75 million, surpassing expectations with a 20.9% year-over-year increase. The company also declared a quarterly dividend of $0.30, representing a 5.9% yield, although its payout ratio is high at 190.48%.
Vanguard Group Inc. Buys 481,231 Shares of Sabra Healthcare REIT, Inc. $SBRA
Vanguard Group Inc. increased its stake in Sabra Healthcare REIT (NASDAQ: SBRA) by 1.4%, purchasing an additional 481,231 shares and bringing its total holding to over 35.4 million shares valued at approximately $671 million. Sabra Healthcare REIT recently beat Q1 revenue and FFO estimates, raised its FY 2026 EPS guidance, and declared a quarterly dividend of $0.30 per share. The company's management, however, noted potential near-term uncertainty regarding capital allocation and payout sustainability due to tight skilled-nursing deal flow and strong competition.
Strs Ohio Has $16.50 Million Stock Position in Sabra Healthcare REIT, Inc. $SBRA
Strs Ohio significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 1,916.2% in Q4, holding 871,000 shares valued at approximately $16.5 million. The company recently reported Q1 results that beat revenue and FFO estimates, raising its FY-2026 EPS guidance and declaring a $0.30 quarterly dividend. Despite a "Moderate Buy" consensus from analysts with a $22 target, concerns remain regarding the high dividend payout ratio (~190%) and potential uncertainties from future guidance review following recent investments.
Wall Street Zen Upgrades Sabra Healthcare REIT (NASDAQ:SBRA) to "Hold"
Wall Street Zen has upgraded Sabra Healthcare REIT (NASDAQ:SBRA) from "sell" to "hold." The company recently beat Q1 revenue and FFO estimates, set FY2026 guidance, and declared a quarterly dividend, contributing to a "Moderate Buy" consensus rating from analysts with an average target price of $22. However, near-term risks include management revisiting 2026 guidance after significant investments and tight competition in the skilled nursing acquisition market.
Sabra Health Care REIT (SBRA) FFO Growth Supports Bullish Narratives In Q1 2026
Sabra Health Care REIT (SBRA) reported strong Q1 2026 Funds From Operations (FFO) of US$95.9 million, contributing to a bullish narrative supported by increased revenue, net income, and expanding margins. While profitability justifies a stronger valuation with a P/E of 33.5x, concerns remain regarding dividend instability, high payout ratio, and interest payments not being well covered by earnings, offering a mixed outlook for investors.
Sabra Health Care REIT surpasses 50 percent private-pay concentration as it continues senior housing growth
Sabra Health Care REIT has achieved over 50% private-pay concentration in its portfolio for the first time, signaling a significant shift in its business model. This milestone was announced during its first-quarter earnings call, highlighting continued expansion in its senior housing operating portfolio (SHOP) and increased net operating income. The company plans further investments in senior living and is leveraging technology, including AI, to enhance operations and resident care.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Declares $0.30 Quarterly Dividend
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has declared a quarterly dividend of $0.30 per share, payable on May 29th to shareholders of record on May 15th, resulting in a 6.0% yield. While the current payout ratio of 153.8% indicates the dividend is not covered by current earnings, the company's strong revenue beat and FY2026 EPS guidance of $1.55-$1.59 suggest future dividend sustainability with an expected payout ratio of 75.5%. The stock traded down $0.25 to $20.10, with a market cap of $5.07 billion.
Vanguard reports 5.28% stake in Sabra Health Care REIT | SBRA SEC Filing - Form SCHEDULE 13G
Vanguard Capital Management has reported a 5.28% stake in Sabra Health Care REIT (SBRA), holding 13,315,431 shares of common stock. The filing, a Schedule 13G, indicates Vanguard has sole dispositive power over all shares and sole voting power over 2,084,683 shares. This ownership includes securities held for various Vanguard funds and managed accounts, with affiliates like Vanguard Asset Management Limited also noted in the disclosure.
Sabra Healthcare REIT 1Q EPS 16c >SBRA
This article provides a brief update on Sabra Healthcare REIT's first-quarter earnings per share, reporting it at 16 cents. The content is very minimal, essentially just stating this financial figure for the company.
Sabra Healthcare REIT (NASDAQ:SBRA) Posts Earnings Results, Beats Expectations By $0.23 EPS
Sabra Healthcare REIT (NASDAQ:SBRA) has reported Q1 earnings of $0.39 EPS, surpassing the consensus estimate by $0.23, and updated its FY2026 EPS guidance to $1.550-$1.590. Despite beating expectations and paying a $0.30 quarterly dividend, the stock traded down on Wednesday. Analysts generally rate SBRA a "Moderate Buy" with a consensus target price of $22.00.
Sabra: Q1 Earnings Snapshot
Sabra Healthcare REIT Inc. (SBRA) reported its first-quarter earnings, showing funds from operations (FFO) of $100.1 million, or 39 cents per share. The real estate investment trust also announced a net income of $40.9 million, or 16 cents per share, on revenue of $221.8 million.
Analysts’ Opinions Are Mixed on These Real Estate Stocks: American Healthcare REIT, Inc. (AHR) and Sun Communities (SUI)
Analysts have mixed opinions on two real estate stocks: American Healthcare REIT, Inc. (AHR) and Sun Communities (SUI). While American Healthcare REIT received a Strong Buy consensus with significant upside potential from analysts like Farrell Granath and BMO Capital, Sun Communities garnered a Moderate Buy consensus. Barry Oxford of Colliers Securities issued a Hold rating for Sun Communities, and Deutsche Bank also downgraded the stock to Hold.
Sabra Healthcare REIT Posts Solid First-Quarter 2026 Results
Sabra Healthcare REIT (SBRA) reported strong first-quarter 2026 results, with net income of $0.16 per diluted share and normalized AFFO of $0.39, supported by significant growth in senior housing NOI. The company expanded its healthcare real estate holdings with over $400 million in investments, maintained moderate leverage, declared a $0.30 quarterly dividend, and reaffirmed its 2026 guidance, highlighting ample liquidity. Analysts view SBRA as a Buy with a $22.00 price target, and TipRanks' AI Analyst rates it as an Outperform due to improving fundamentals and a constructive earnings outlook.
Sabra Health Care REIT (NASDAQ: SBRA) grows Q1 2026 AFFO and confirms outlook
Sabra Health Care REIT (SBRA) reported strong first-quarter 2026 results, with Adjusted Funds From Operations (AFFO) reaching $0.39 per diluted share, an increase from the prior year. The company reaffirmed its full-year 2026 guidance and announced a quarterly dividend of $0.30 per share. Sabra also highlighted a 14.4% year-over-year increase in Same Property Managed Senior Housing Cash Net Operating Income (NOI) and significant investment activity in senior housing and skilled nursing assets with high cash yields.
Sabra Reports First Quarter 2026 Results; Reiterates 2026 Guidance
Sabra Health Care REIT, Inc. announced strong first quarter 2026 results, including a 14.4% increase in same property managed senior housing Cash NOI year-over-year. The company reported diluted earnings per share of $0.16 and reiterated its full-year guidance, driven by robust investment activity and high rent coverage across its triple net asset classes. Sabra also declared a quarterly cash dividend of $0.30 per share and highlighted its significant liquidity position.
Sabra Healthcare REIT faces earnings test after Q4 shortfall
Sabra Healthcare REIT is poised to release its first-quarter earnings, with investors keenly focused on whether the company can recover from a significant fourth-quarter earnings miss. Despite a projected year-over-year EPS decline, analysts anticipate sequential improvement and maintain a "Buy" rating with a target price reflecting a 7.3% upside. The report will be crucial for assessing the sustainability of operational improvements and the achievement of management's 2026 financial guidance, especially given the company's strategic shift towards managed senior housing and the overall positive outlook for the healthcare REIT sector.
Sabra Health Care REIT, Landmark Recovery Call It Quits in Court
Sabra Health Care REIT and addiction treatment provider Landmark Recovery have reached a court-approved settlement, ending their years-long partnership after disputes over missed rent payments and Landmark's bankruptcy. The agreement mandates Landmark Recovery to pay Sabra $52.5 million to acquire five facilities, including those involved in the bankruptcy proceedings, and return other leased properties within a specified timeframe. The settlement also requires Landmark to address significant property damage at several facilities while continuing monthly rent payments until the deal closes.
Advisors Capital Management LLC Acquires 73,281 Shares of Sabra Healthcare REIT, Inc. $SBRA
Advisors Capital Management LLC has increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.2%, acquiring an additional 73,281 shares, bringing their total holdings to 2,382,935 shares valued at approximately $45.13 million. This comes as Sabra Healthcare REIT reported Q4 EPS of $0.11, missing the consensus estimate of $0.37, despite a 16.2% year-over-year revenue increase to $201.35 million. The company announced a quarterly dividend of $0.30, resulting in an annualized yield of 6.0%.
Universal Beteiligungs und Servicegesellschaft mbH Acquires 86,206 Shares of Sabra Healthcare REIT, Inc. $SBRA
Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Sabra Healthcare REIT, Inc. by 10.4% in the fourth quarter, acquiring 86,206 additional shares and bringing its total holdings to 918,167 shares valued at approximately $17.42 million. Sabra Healthcare REIT, Inc. recently reported missing quarterly EPS expectations despite a 16.2% increase in revenue year-over-year, and has set its FY2026 EPS guidance between $1.550-$1.590. The company pays a $0.30 quarterly dividend, resulting in a 6.0% yield, but its payout ratio is notably high at 187.5%.
Sabra Health Care REIT (NASDAQ: SBRA) sets 2026 votes on directors, auditor and pay
Sabra Health Care REIT (NASDAQ: SBRA) released its 2026 proxy statement, detailing the upcoming annual stockholder meeting on June 17, 2026. Key agenda items include the election of directors, ratification of PwC as the independent auditor for 2026, and a non-binding advisory vote on named executive officer compensation. The proxy emphasizes the board's independence, performance-based executive pay with significant equity deferral, and the company's commitment to sustainability and diversity.
Sabra Healthcare REIT (SBRA) Projected to Post Earnings on Wednesday
Sabra Healthcare REIT (SBRA) is scheduled to announce its Q1 2026 earnings on Wednesday, April 29th, with analysts forecasting EPS of $0.1627 and revenue of $204.534 million. The company previously missed Q4 EPS estimates, reporting $0.11 against an expected $0.37, despite a 16.2% year-over-year revenue increase. Sabra's dividend payout ratio is currently high at 187.5%, raising concerns about its sustainability, even with an attractive 6.0% yield.
CEO, CFO and CIO join Sabra team at Wells Fargo REIT conference
Sabra Health Care REIT, Inc. announced that its CEO Rick Matros, CFO Michael Costa, CIO Darrin Smith, and EVP of Finance Lukas Hartwich will attend Wells Fargo's 29th Annual Real Estate Securities Conference from May 4-6, 2026. Sabra Health Care REIT is a self-administered real estate investment trust focused on the healthcare industry in the United States and Canada. This attendance highlights the company's engagement with the financial community.
Leisure Capital Management Boosts Position in Sabra Healthcare REIT, Inc. $SBRA
Leisure Capital Management significantly increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 9.8% in Q4, making it their 5th largest holding valued at $11.04 million. Despite the REIT missing Q4 earnings estimates, its revenue grew by 16.2% year-over-year, and it provided an optimistic FY2026 EPS guidance. Investors are drawn to Sabra's quarterly dividend with an annualized yield of 5.8%, though a high payout ratio and concentration of institutional ownership present potential risks.
Sabra Health Care REIT, Inc. to Attend Wells Fargo’s 29th Annual Real Estate Securities Conference
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced that its key executives, including Chair and CEO Rick Matros and CFO Michael Costa, will attend Wells Fargo’s 29th Annual Real Estate Securities Conference from May 4-6, 2026. The conference will take place at The Charleston Place in Charleston, South Carolina. Sabra is a self-administered real estate investment trust focused on the healthcare industry in the United States and Canada.
Sabra Health Care REIT, Inc. Sees Revision in Stock Evaluation Amid Market Dynamics
Sabra Health Care REIT, Inc. has undergone a stock evaluation revision, showing a year-to-date return of 9.08%, outperforming the S&P 500, and a three-year return of 77.34%, also surpassing the index. Technical indicators suggest a generally positive outlook despite a mildly bearish trend on the monthly KST. The stock is currently priced at $20.66.
Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA
Sumitomo Mitsui Trust Group Inc. significantly increased its stake in Sabra Healthcare REIT, Inc. by 1,019.8% in Q4, acquiring over 2.7 million shares and holding approximately 1.21% of the company. This comes despite Sabra missing quarterly EPS expectations, though revenue increased year-over-year. The REIT offers a 5.9% dividend yield and has a "Moderate Buy" consensus rating from analysts with an average price target of $22.00.
Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Passes Above Two Hundred Day Moving Average - Here's Why
Sabra Healthcare REIT (NASDAQ:SBRA) recently saw its stock price climb above its 200-day moving average, reaching $20.49 with strong trading volume. Several analysts have raised their price targets for SBRA, contributing to a "Moderate Buy" consensus rating with a target of $22.00. Despite missing quarterly EPS estimates, the company reported 16.2% year-over-year revenue growth and offers a 5.9% dividend yield.
Sabra Health Care REIT sets April 30 call on first-quarter results
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced that it will release its first-quarter 2026 earnings on April 29, 2026, after the close of trading. The company will also host a conference call and webcast to discuss these results on April 30th at 10:00 a.m. Pacific Time. Sabra is a real estate investment trust specializing in healthcare properties across the United States and Canada.
Sabra Health Care REIT Announces Q1 2026 Earnings Release
Sabra Health Care REIT, focused on healthcare properties, will release its Q1 2026 financial results on April 29, 2026, and host a conference call the same day. This report is crucial for understanding the current state and outlook of the healthcare real estate market, including senior housing and skilled nursing facilities. Investors will be looking for signs of recovery or challenges in the sector.
Sabra Health Care REIT, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics
Sabra Health Care REIT, Inc. recently underwent a stock evaluation revision due to changing market conditions. The company's stock currently stands at $20.24, with a year-to-date return of 6.86% and a three-year return of 89.34%, outperforming the S&P 500 over that extended period. Technical indicators show mixed signals, with bullish signs in weekly MACD and KST but a bearish monthly RSI.
SBRA Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial overview of Sabra Health Care REIT Inc (SBRA), detailing its profitability margins and comparing it to competitors. SBRA maintains a gross margin of 63.75%, an operating margin of 30.48%, and a net margin of 12.81%, with a Return on Equity (ROE) of 5.59%. The company, with a market capitalization of $5.06 billion, is benchmarked against industry leaders like PECO and MAC, highlighting its competitive position regarding efficiency.
406,413 Shares in Sabra Healthcare REIT, Inc. $SBRA Bought by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL has acquired a new position in Sabra Healthcare REIT (NASDAQ:SBRA), purchasing 406,413 shares valued at approximately $7.58 million. Despite this institutional interest, Sabra Healthcare REIT faces challenges, including a high payout ratio of 187.5% and a recent miss on quarterly EPS, highlighting potential sustainability risks although analysts maintain a "Moderate Buy" consensus. The company recently declared a quarterly dividend of $0.30 per share, representing a 6.0% annual yield.
Sound Income Strategies LLC Purchases 147,698 Shares of Sabra Healthcare REIT, Inc. $SBRA
Sound Income Strategies LLC increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 20.5% during the fourth quarter, purchasing 147,698 additional shares to own a total of 869,108 shares worth approximately $16.7 million. Despite the company missing recent quarterly EPS estimates and having a high payout ratio of 187.5%, analysts maintain a "Moderate Buy" consensus rating with an average target price of $22.00. Sabra Healthcare REIT, which pays a quarterly dividend of $0.30, saw its revenue increase by 16.2% year-over-year.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Recommendation of "Moderate Buy" by Brokerages
Ten brokerages have given Sabra Healthcare REIT (NASDAQ:SBRA) an average "Moderate Buy" recommendation, with an average 12-month target price of $22.00, and some firms have recently raised their price targets. Despite missing Q4 EPS estimates and having a high dividend payout ratio of 187.5%, the company saw 16.2% revenue growth and is heavily owned by institutional investors. Sabra Healthcare REIT, which acquires and operates net-lease healthcare properties, is trading around $19.86 with a market cap of $5.01 billion.
Vanguard disaggregates holdings; reports 0% in Sabra Health Care REIT (SBRA)
Vanguard has filed a Schedule 13G/A amendment for Sabra Health Care REIT (SBRA), reporting 0% beneficial ownership due to an internal realignment effective January 12, 2026. This realignment means certain Vanguard subsidiaries will now report their holdings separately. The filing clarifies that this change does not reflect a sale of shares but rather a restructuring of reporting in accordance with SEC Release No. 34-39538.
Sabra Health Care (SBRA) EVP sells 15,231 shares at $19.86
Jessica Flores, Executive VP & CAO of Sabra Health Care REIT, Inc. (SBRA), sold 15,231 shares of common stock on March 25, 2026, at a weighted average price of $19.86 per share. Following this transaction, she directly holds 71,709 shares, a figure that includes 25,527 stock units convertible to common stock. This insider trading activity is noted as having a moderate impact and negative sentiment.
Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $22.00 at Wells Fargo & Company
Wells Fargo & Company has increased its price target for Sabra Healthcare REIT (NASDAQ:SBRA) from $21.00 to $22.00, maintaining an "overweight" rating and suggesting a 10.57% upside. This adjustment comes despite Sabra reporting an earnings miss of $0.11 EPS versus $0.37 expected, though revenue did rise 16.2% year-over-year. The company has set its FY2026 guidance at 1.550–1.590 EPS, exceeding analyst forecasts of around 1.45 EPS.
